Is your assay amenable to ultra-High-Throughput Screening? Seven aspects to consider…
Beyond doubt, major improvements in robotics and flexible automation over the last decades have made uHTS a mainstay in hit
Is your assay amenable to ultra-High-Throughput Screening? Seven aspects to consider…
Beyond doubt, major improvements in robotics and flexible automation over the last decades have made uHTS a mainstay in hit
Five reasons for a startup to outsource a screen to PPSC
Even though the success rates in discovery and development of new medicines remain extremely low, many innovative biotech companies are
Webinar-on-demand: Could Mass Spec be the next break-through in High-Throughput Screening?
In this webinar we will present the implementation and capabilities of Mass Spec-uHTS as a fully automated screening platform and future applications of MS-uHTS.
Webinar on-demand: Hit finding for crowd-sourced disease targets
Watch this webinar to learn about Pivot Park Screening Centre (PPSC) contributions to the European Lead Factory (ELF), hit finding efforts for > 70 crowd-sourced drug targets & lessons learnt from assay development and uHTS output within ELF.
Hit Discovery for Public Target Programs in the European Lead Factory
Experiences and Output from Assay Development and Ultra-High-Throughput Screening. Publication by: Honarnejad, S., van Boeckel, S., van den Hurk, H.,
The European Lead Factory selects first COVID-19 proposal
Over the last few months, as the world has grappled with the COVID-19 pandemic, the European Lead Factory has been
One of the sub-projects of the MMV-PDP Consortium recently received funding from the Bill and Melinda Gates Foundation, to further develop an
ZeGlobalTox – a rapid and reliable preclinical screening tool
The zebrafish (Danio rerio) is a tropical fish with a genetic structure surprisingly similar to ours. However, they’ve become a
Novel Screening Assay for Arginase-1 Inhibitors published in SLAS Discovery
Arginase-1 is a promising new drug target for cancer immunotherapy. A novel assay technology for High-Throughput Screening (HTS) of Arginase-1
NTRC publishes High-Throughput Screening assay for IDO1 and TDO in Journal of Biomolecular Screening
Immunotherapy is one of the recent advances in cancer treatment. Cancer immunotherapy makes use of the body’s immune system to
Subscribe to our newsletter
Pivot Park – Banting Building (RE600)
Kloosterstraat 9
5349 AB Oss
The Netherlands
Pivot Park Screening Centre
Building OP
Kloosterstraat 9
5349 AB Oss
The Netherlands